
Roche’s Sam Ogden joins the ABPI
pharmafile | November 25, 2010 | Appointment | Medical Communications, Sales and Marketing | ABPI, Sam Ogden, appointment, medical communications, sales and marketing
The ABPI has appointed Sam Ogden as membership engagement account director.
She is currently head of in-field effectiveness at Roche and will join the UK pharma industry association on 10 January 2011.
Sam has worked at Roche for ten years, holding a variety of senior sales, marketing and business unit head roles.
Prior to joining Roche she held commercial roles at AstraZeneca and SmithKline Beecham.
In her new role she will be reporting to ABPI commercial director Alison Clough.
Alison said: “Sam will ensure that we engage more proactively with all our members, in particular the small-mid size companies and will play a key role in ensuring their views and needs are fully represented in our campaigns.”
Related Content

Rare diseases – spinal muscular atrophy
Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …






